Upon starting methotrexate treatment, LDH and albumin levels may be signals for AKIs in patients with hematologic malignancies.
In critically ill patients with acute kidney injury, more intensive renal replacement therapy may lead to a greater risk of failure to extubate from mechanical ventilation.
Kidney failure due to acute kidney injury is associated with a significantly higher death risk in the first 6 months following dialysis initiation than kidney failure resulting from diabetes, a study found.
In a propensity score matched analysis, patients with a history of acute kidney injury (AKI) had a significant 43% lower risk of kidney stones than those who never experienced AKI.
Of patients admitted to ICU, 78.0% developed acute kidney injury, 35.2% needed dialysis.
The first large-scale study to characterize acute kidney injury (AKI) in COVID-19 patients indicates that AKI develops mostly among patients requiring mechanical ventilation.
A new meta-analysis suggests that severe acute kidney injury that develops in hospitalized COVID-19 patients is significantly associated with a 4-fold increased risk of death.
Study findings further support the use of SGLT2 inhibitors in a broad range of patients with type 2 diabetes, according to investigators.
New findings from a systematic review and meta-analysis suggest that renal replacement therapy can be safely postponed in many critically ill patients with acute kidney injury.
Acute kidney injury may develop in up to 30% of COVID-19 patients in intensive care units, according to a nephrologist at Emory University School of Medicine in Atlanta.